인라이븐 테라퓨틱스
ELVN · 최근 20건
0
매수
20
매도
−$14.5M
순매수
거래 내역
Derynck Mika K
Director · 2026. 8. 4.
−$217K
매도
Derynck Mika K
Director · 2026. 8. 4.
−$347K
매도
Derynck Mika K
Director · 2026. 8. 4.
−$697K
매도
Derynck Mika K
Director · 2026. 8. 4.
−$460K
매도
Derynck Mika K
Director · 2026. 8. 4.
−$9.6M
매도
Collins Helen Louise
CHIEF MEDICAL OFFICER · 2026. 7. 17.
−$117K
매도
Collins Helen Louise
CHIEF MEDICAL OFFICER · 2026. 7. 17.
−$3K
매도
Hohl Benjamin
CHIEF FINANCIAL OFFICER · 2026. 7. 17.
−$19K
매도
Collins Helen Louise
CHIEF MEDICAL OFFICER · 2026. 7. 17.
−$12K
매도
Hohl Benjamin
CHIEF FINANCIAL OFFICER · 2026. 7. 17.
−$7K
매도
Collins Helen Louise
CHIEF MEDICAL OFFICER · 2026. 7. 17.
−$12K
매도
Collins Helen Louise
CHIEF MEDICAL OFFICER · 2026. 7. 17.
−$108K
매도
Hohl Benjamin
CHIEF FINANCIAL OFFICER · 2026. 7. 17.
−$134K
매도
Hohl Benjamin
CHIEF FINANCIAL OFFICER · 2026. 7. 17.
−$3K
매도
Hohl Benjamin
CHIEF FINANCIAL OFFICER · 2026. 7. 17.
−$16K
매도
Hohl Benjamin
CHIEF FINANCIAL OFFICER · 2026. 7. 17.
−$141K
매도
Collins Helen Louise
CHIEF MEDICAL OFFICER · 2026. 7. 17.
−$24K
매도
Kunkel Lori Anne
Director · 2026. 7. 6.
−$205K
매도
Kunkel Lori Anne
Director · 2026. 7. 6.
−$299K
매도
OrbiMed Genesis GP LLC
10% Owner · 2026. 6. 22.
−$2.1M
매도